Nurse-assisted Intervention "eHealth@ Hospital -2-home"
NCT05750953
Cardiovascular Diseases, Colon Rectal Cancer
Stavanger, Rogaland, Norway
View Trial DetailsNCT Number: NCT01244308
It's the aim of this study to analyse efficacy and reliability of VectSelect Feature for avoidance of phrenic nerve stimulation in cardiac resynchronisation therapy (CRT) patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Medizinische Einrichtungen der RWTH Aachen, Aachen, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: First Follow Up after hospital discharge (approx. 1-3 months)
Amount of patients with at least one acceptable, programmable LV pacing configuration. Definition of acceptable LV pacing configuration: LV pacing threshold <[email protected] AND Phrenic nerve threshold is at least twice as high as LV pacing threshold AND LV pacing impedance >=200 Ohms.
Only patients with implanted CRT-D and bipolar leftventricular lead are taken into account.
Abbott Medical Devices
Industry
Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic Nerve Stimulation in CRT Patients
Acronym: Efface
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05750953
Cardiovascular Diseases, Colon Rectal Cancer
Stavanger, Rogaland, Norway
View Trial DetailsNCT02061319
Cardiovascular Diseases, Heart Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT06576050
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial DetailsNCT04113109
Cardiovascular Diseases, Heart Diseases
Nashville, Tennessee, United States
View Trial Details